DRP Journal

Pasithea Therapeutics (NASDAQ:KTTA) Stock Makes a Big Move: Jumps To All-Time High

Pasithea Therapeutics (NASDAQ:KTTA) was up 155% on Tuesday after the company added esketamine nasal spray to its offerings in the